NOTICE: Thank you for visiting our site. Your experience is important to us. We're upgrading our system to better serve you. During this time, purchases and member logins will be unavailable. Full functionality will be restored by Monday, 29 July.
Jo Anne Valentino
New York Blood Center
Vice President, Quality and Regulatory Affairs
Jo Anne Valentino is the Vice President of Quality and Regulatory Affairs at New York Blood Center Enterprises and has quality oversight of the Comprehensive Cell Solutions department.
Prior to joining NYBCe, Jo Anne was an independent consultant to the life sciences industry supporting clients FDA inspection readiness activities.
Prior, Jo Anne served as Chief Operating Officer of Minaris Regenerative Medicine, LLC, a US based CDMO for the cell therapy industry. After joining Minaris in January 2019, Jo Anne served as Global Head of Quality for the Regenerative Medicine Business Sector of Showa Denko Materials Co., Ltd. and Vice President of Minaris (United States). She was appointed COO of Minaris’ United States operations in October 2021. In this role, she was responsible for oversight of all US development and manufacturing operations.
For more than seven years, Jo Anne worked at Novartis in quality positions of increasing responsibility, including Executive Director, Quality Head, External Supply Operations, Americas region. In that role, she ensured robust quality oversight for a large portfolio of external suppliers and supported strategic initiatives in the region, product launches and transfers, business integrations, and global compliance improvement initiatives. Prior to Novartis, Jo Anne was in leadership positions at Merck and Schering-Plough in operations and quality, as well as product and process development at Reckitt Benckiser.
Jo Anne holds a MS in management from Stevens Institute of Technology and a BS in chemical engineering from Manhattan College.
Prior to joining NYBCe, Jo Anne was an independent consultant to the life sciences industry supporting clients FDA inspection readiness activities.
Prior, Jo Anne served as Chief Operating Officer of Minaris Regenerative Medicine, LLC, a US based CDMO for the cell therapy industry. After joining Minaris in January 2019, Jo Anne served as Global Head of Quality for the Regenerative Medicine Business Sector of Showa Denko Materials Co., Ltd. and Vice President of Minaris (United States). She was appointed COO of Minaris’ United States operations in October 2021. In this role, she was responsible for oversight of all US development and manufacturing operations.
For more than seven years, Jo Anne worked at Novartis in quality positions of increasing responsibility, including Executive Director, Quality Head, External Supply Operations, Americas region. In that role, she ensured robust quality oversight for a large portfolio of external suppliers and supported strategic initiatives in the region, product launches and transfers, business integrations, and global compliance improvement initiatives. Prior to Novartis, Jo Anne was in leadership positions at Merck and Schering-Plough in operations and quality, as well as product and process development at Reckitt Benckiser.
Jo Anne holds a MS in management from Stevens Institute of Technology and a BS in chemical engineering from Manhattan College.